Pfizer Inc. (PFE) announced on Thursday that its current Chief Financial Officer, Dave Denton, will depart the company on August 15 for an opportunity outside the pharmaceutical industry in consumer goods.
Stepping into the role as interim CFO on August 16 will be Cecile Guegan, who currently holds the title of senior vice president of finance for Pfizer's global biopharmaceutical business. She brings more than 20 years of experience in financial operations.
The company noted that it will conduct an internal and external search for a permanent hire. Pfizer said the two executives will collaborate during the handover period.
Albert Bourla, Chairman and Chief Executive Officer of Pfizer, said, "Cecile's deep institutional knowledge and financial acumen will help lead Pfizer's finance organization and will keep us focused to execute our strategy for patients and shareholders."
PFE is currently trading at $24.99, down 3.61%.
For more such biotech stock news, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.